|
Samir Kaul is a founding general partner at Khosla Ventures and is focusing on clean technologies and life sciences investing. Since joining forces with Khosla, Samir has led the firm�s investments in Altra, Amyris, Cilion, Great Point Energy, Mascoma, Stion and a number of earlier science projects. Before joining Khosla Ventures, Samir was a partner at Flagship Ventures where he was a member of the Life Sciences team from 2002 through 2005. During that time he was also the founding-CEO of two Flagship start-ups, Codon Devices and Epitome Biosystems, and part of the founding team of a third Flagship start-up, Helicos Bio-Sciences. Prior to Flagship, Samir worked at the Institute for Genomic Research (TIGR). At TIGR, Samir led the Arabidopsis thaliana sequencing project, the first plant genome to be completely sequenced. | 